Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) EPS (Basic): 2021-2024

Historic EPS (Basic) for Abivax (ABVX) over the last 4 years, with Dec 2024 value amounting to -$2.99.

  • Abivax's EPS (Basic) fell 30.25% to -$0.86 in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.40, marking a year-over-year decrease of 70.72%. This contributed to the annual value of -$2.99 for FY2024, which is 18.92% up from last year.
  • Latest data reveals that Abivax reported EPS (Basic) of -$2.99 as of FY2024, which was up 18.92% from -$3.69 recorded in FY2023.
  • In the past 5 years, Abivax's EPS (Basic) registered a high of -$2.99 during FY2024, and its lowest value of -$3.69 during FY2023.
  • Over the past 3 years, Abivax's median EPS (Basic) value was -$3.35 (recorded in 2022), while the average stood at -$3.34.
  • In the last 5 years, Abivax's EPS (Basic) decreased by 10.11% in 2023 and then rose by 18.92% in 2024.
  • Yearly analysis of 4 years shows Abivax's EPS (Basic) stood at -$3.25 in 2021, then dropped by 2.99% to -$3.35 in 2022, then fell by 10.11% to -$3.69 in 2023, then rose by 18.92% to -$2.99 in 2024.